Growth Metrics

Tandem Diabetes Care (TNDM) EPS (Basic) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.42%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.04%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.88%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 95.65%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 8.20%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 92.59%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.89%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.01%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 84.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 84.77%
Dec 31, 2025 -200.00%
Sep 30, 2025 11.43%
Jun 30, 2025 -65.96%
Mar 31, 2025 -203.08%
Dec 31, 2024 102.17%
Sep 30, 2024 31.37%
Jun 30, 2024 14.55%
Mar 31, 2024 66.15%
Dec 31, 2023 -84.00%
Sep 30, 2023 32.89%
Jun 30, 2023 -139.13%
Mar 31, 2023 -734.78%
Dec 31, 2022 -247.06%
Sep 30, 2022 -944.44%
Jun 30, 2022 -483.33%
Mar 31, 2022 -187.50%
Dec 31, 2021 -37.04%
Sep 30, 2021 160.00%
Jun 30, 2021 113.33%
Mar 31, 2021 68.00%
Dec 31, 2020 575.00%
Sep 30, 2020 -200.00%
Jun 30, 2020 -1,400.00%
Mar 31, 2020 37.50%
Dec 31, 2019 -33.33%
Sep 30, 2019 91.94%
Jun 30, 2019 97.44%
Mar 31, 2019 78.02%
Dec 31, 2018 104.88%
Sep 30, 2018 79.94%
Jun 30, 2018 73.17%
Mar 31, 2018 75.60%
Dec 31, 2017 74.37%
Sep 30, 2017 68.14%
Jun 30, 2017 27.33%
Mar 31, 2017 -9.71%
Dec 31, 2016 -1,100.00%
Sep 30, 2016 -1,392.31%
Jun 30, 2016 -823.08%
Mar 31, 2016 -719.28%
Dec 31, 2015 48.72%
Sep 30, 2015 23.53%
Jun 30, 2015 21.69%
Mar 31, 2015 13.54%
Dec 31, 2014 63.55%
Sep 30, 2014 98.61%
Jun 30, 2014 98.86%
Mar 31, 2014 98.21%